<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cells</journal-id>
<journal-id journal-id-type="iso-abbrev">Cells</journal-id>
<journal-id journal-id-type="publisher-id">cells</journal-id>
<journal-title-group>
<journal-title>Cells</journal-title>
</journal-title-group>
<issn pub-type="epub">2073-4409</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29140302</article-id>
<article-id pub-id-type="pmc">5755501</article-id>
<article-id pub-id-type="doi">10.3390/cells6040043</article-id>
<article-id pub-id-type="publisher-id">cells-06-00043</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Danger: High Voltage—The Role of Voltage-Gated Calcium Channels in Central Nervous System Pathology</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Schampel</surname>
<given-names>Andrea</given-names>
</name>
<xref ref-type="aff" rid="af1-cells-06-00043">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6119-605X</contrib-id>
<name>
<surname>Kuerten</surname>
<given-names>Stefanie</given-names>
</name>
<xref ref-type="aff" rid="af2-cells-06-00043">2</xref>
<xref ref-type="corresp" rid="c1-cells-06-00043">*</xref>
</contrib>
</contrib-group>
<aff id="af1-cells-06-00043"><label>1</label>Institute of Anatomy and Cell Biology, University of Würzburg, 97070 Würzburg, Germany; <email>andrea.schampel@uni-wuerzburg.de</email></aff>
<aff id="af2-cells-06-00043"><label>2</label>Institute of Anatomy and Cell Biology, Friedrich-Alexander University Erlangen-Nürnberg, 91054 Erlangen, Germany</aff>
<author-notes>
<corresp id="c1-cells-06-00043"><label>*</label>Correspondence: <email>stefanie.kuerten@fau.de</email>; Tel.: +49-9131-85-22264</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<month>12</month>
<year>2017</year>
</pub-date>
<volume>6</volume>
<issue>4</issue>
<elocation-id>43</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>9</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 by the authors.</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Voltage-gated calcium channels (VGCCs) are widely distributed within the central nervous system (CNS) and presumed to play an important role in the pathophysiology of a broad spectrum of CNS disorders including Alzheimer’s and Parkinson’s disease as well as multiple sclerosis. Several calcium channel blockers have been in clinical practice for many years so that their toxicity and side effects are well studied. However, these drugs are primarily used for the treatment of cardiovascular diseases and most if not all effects on brain functions are secondary to peripheral effects on blood pressure and circulation. While the use of calcium channel antagonists for the treatment of CNS diseases therefore still heavily depends on the development of novel strategies to specifically target different channels and channel subunits, this review is meant to provide an impulse to further emphasize the importance of future research towards this goal.</p>
</abstract>
<kwd-group>
<kwd>calcium</kwd>
<kwd>calcium channel antagonists</kwd>
<kwd>CNS</kwd>
<kwd>EAE</kwd>
<kwd>neurodegeneration</kwd>
<kwd>MS</kwd>
<kwd>regeneration</kwd>
<kwd>remyelination</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-cells-06-00043">
<title>1. Calcium and Voltage-Gated Calcium Channels (VGCCs)</title>
<p>Calcium is one of the most important intracellular second messengers in the central nervous system (CNS). It regulates numerous cellular processes due to its electrogenic properties. These processes include neurotransmitter release, excitation, cell growth, proliferation, gene expression, long-term potentiation, plasticity and apoptosis [<xref ref-type="bibr" rid="B1-cells-06-00043">1</xref>,<xref ref-type="bibr" rid="B2-cells-06-00043">2</xref>,<xref ref-type="bibr" rid="B3-cells-06-00043">3</xref>]. In order to trigger and maintain Ca<sup>2+</sup>-dependent processes, an influx of cytosolic calcium from the extracytoplasmic space is required. This is achieved by calcium release from internal calcium stores or by entry of calcium ions via the cell membrane. In electrically excitable cells, voltage-gated calcium channels (VGCCs) are the main route for calcium entry into the cell after depolarization of the membrane. Despite mediating calcium influx, VGCCs also regulate intracellular processes depending on their localization. In cardiomyocytes, VGCCs regulate contraction processes; in endocrine cells, they control the secretion of hormones and in the CNS, they modulate the release of neurotransmitters [<xref ref-type="bibr" rid="B4-cells-06-00043">4</xref>]. Structurally, VGCCs are heteromultimeric complexes consisting of a central pore-forming Ca<sub>v</sub>α1 subunit, which is conductive for ions. The central pore-forming subunit is convoyed by several auxiliary subunits (α2δ1-4, β1-4 and γ1-8) [<xref ref-type="bibr" rid="B5-cells-06-00043">5</xref>,<xref ref-type="bibr" rid="B6-cells-06-00043">6</xref>]. So far, ten different Ca<sub>v</sub>α1 subunits have been described and classified according to their pharmacological and electrophysiological properties into high-voltage activated (HVA) and low-voltage activated (LVA) Ca<sup>2+</sup> channels [<xref ref-type="bibr" rid="B4-cells-06-00043">4</xref>,<xref ref-type="bibr" rid="B5-cells-06-00043">5</xref>]. HVA Ca<sup>2+</sup> channels include dihydropyridine-sensitive L (“long-lasting”)-type Ca<sub>v</sub>1.1–1.4 and non-L-type Ca<sub>v</sub>2.1–2.3 channels, which are less sensitive for DHP. Compared to LVA channels, which consist of the T (“transient”)-type Ca<sup>2+</sup> channels Ca<sub>v</sub>3.1–3.3, HVA channels require much stronger depolarization to reach the activation threshold. Additionally, they show prolonged channel opening [<xref ref-type="bibr" rid="B4-cells-06-00043">4</xref>,<xref ref-type="bibr" rid="B5-cells-06-00043">5</xref>,<xref ref-type="bibr" rid="B6-cells-06-00043">6</xref>] (<xref ref-type="table" rid="cells-06-00043-t001">Table 1</xref>).</p>
<p>Within the nervous system, several types of VGCCs are expressed. They are detectable in many brain areas such as the cortex, thalamus and the hippocampus. P/Q-, T- and N-type VGCCs are the most common ones in the CNS [<xref ref-type="bibr" rid="B7-cells-06-00043">7</xref>]. Presynaptic P/Q- and N-type VGCCs induce neurotransmitter release and T-type VGCCs facilitate rhythmic burst firing of neurons. L-type VGCCs are localized on neuronal cell bodies as well as on dendrites and spines. Postsynaptic L-type VGCCs regulate gene expression and neuronal excitability (<xref ref-type="fig" rid="cells-06-00043-f001">Figure 1</xref>) [<xref ref-type="bibr" rid="B4-cells-06-00043">4</xref>]. Some types of glial cells such as astrocytes, oligodendrocytes and glial precursor cells have also been shown to express VGCCs [<xref ref-type="bibr" rid="B2-cells-06-00043">2</xref>,<xref ref-type="bibr" rid="B8-cells-06-00043">8</xref>,<xref ref-type="bibr" rid="B9-cells-06-00043">9</xref>,<xref ref-type="bibr" rid="B10-cells-06-00043">10</xref>,<xref ref-type="bibr" rid="B11-cells-06-00043">11</xref>]. Outside the nervous system the heart, skeletal muscle cells, cells of the retina, endocrine cells, cochlear hair cells and cells of the immune system have been reported to express VGCCs or VGCC-like channels (<xref ref-type="fig" rid="cells-06-00043-f001">Figure 1</xref>) [<xref ref-type="bibr" rid="B12-cells-06-00043">12</xref>,<xref ref-type="bibr" rid="B13-cells-06-00043">13</xref>,<xref ref-type="bibr" rid="B14-cells-06-00043">14</xref>,<xref ref-type="bibr" rid="B15-cells-06-00043">15</xref>].</p>
</sec>
<sec id="sec2-cells-06-00043">
<title>2. Signs of Calcium-Mediated Cellular Damage</title>
<p>Intracytoplasmic calcium levels have to be strictly regulated in order to prevent cellular damage. In the CNS, neuronal organelles such as neurofilaments—and in particular mitochondria—are vulnerable to cytotoxicity [<xref ref-type="bibr" rid="B3-cells-06-00043">3</xref>,<xref ref-type="bibr" rid="B16-cells-06-00043">16</xref>,<xref ref-type="bibr" rid="B17-cells-06-00043">17</xref>,<xref ref-type="bibr" rid="B18-cells-06-00043">18</xref>,<xref ref-type="bibr" rid="B19-cells-06-00043">19</xref>]. Mitochondria play different roles in organisms, which comprise cellular respiration, temporary calcium storage, calcium buffering, maintenance of structural integrity and mediation of apoptosis [<xref ref-type="bibr" rid="B19-cells-06-00043">19</xref>,<xref ref-type="bibr" rid="B20-cells-06-00043">20</xref>,<xref ref-type="bibr" rid="B21-cells-06-00043">21</xref>]. Mitochondrial function can be directly influenced by extracellular signalling molecules. Increased nitric oxide (NO) levels, for instance, can alter gene expression and induce dysfunction of mitochondria. This in turn causes dysregulation of calcium homeostasis, resulting in enhanced cellular degeneration [<xref ref-type="bibr" rid="B19-cells-06-00043">19</xref>] and finally apoptosis of neurons and oligodendrocytes. Mitochondrial dysfunction can be detected ultrastructurally by an increased size (<italic>swelling</italic>) of mitochondria, reflecting an enhanced local energy demand [<xref ref-type="bibr" rid="B20-cells-06-00043">20</xref>,<xref ref-type="bibr" rid="B22-cells-06-00043">22</xref>,<xref ref-type="bibr" rid="B23-cells-06-00043">23</xref>]. Increased intracytoplasmic calcium levels also weaken neuronal integrity as they promote breakdown of the cytoskeleton, including actin, tubulin and intermediate filaments. This becomes evident both histologically and ultrastructurally as cytoplasmic <italic>blebbing</italic> and accumulation or dissolution of filaments [<xref ref-type="bibr" rid="B24-cells-06-00043">24</xref>,<xref ref-type="bibr" rid="B25-cells-06-00043">25</xref>]. Other detectable signs of calcium-mediated damage are dilatation of the endoplasmic reticulum and cytosolic shrinkage [<xref ref-type="bibr" rid="B24-cells-06-00043">24</xref>,<xref ref-type="bibr" rid="B25-cells-06-00043">25</xref>].</p>
</sec>
<sec id="sec3-cells-06-00043">
<title>3. VGCCs in the Pathophysiology and Treatment of CNS Diseases</title>
<p>Studies of human diseases, mouse, rat and cell culture models indicate an important contribution of VGCCs to several neurological and psychiatric disorders, blindness and pain (<xref ref-type="table" rid="cells-06-00043-t002">Table 2</xref>) [<xref ref-type="bibr" rid="B26-cells-06-00043">26</xref>]. Of these conditions in particular Parkinson’s and Alzheimer’s disease have been in the focus of research mainly due to their tremendous socioeconomic relevance. In Parkinson’s disease, it has been demonstrated that dihydropyridines—potent VGCC antagonists—reduce the overall population risk in humans [<xref ref-type="bibr" rid="B27-cells-06-00043">27</xref>,<xref ref-type="bibr" rid="B28-cells-06-00043">28</xref>]. Evaluation of the pathogenesis of Alzheimer’s disease has revealed that pathogenic amyloid β (Aβ) peptides elevate L-type VGCC activity in cell cultures [<xref ref-type="bibr" rid="B29-cells-06-00043">29</xref>,<xref ref-type="bibr" rid="B30-cells-06-00043">30</xref>,<xref ref-type="bibr" rid="B31-cells-06-00043">31</xref>,<xref ref-type="bibr" rid="B32-cells-06-00043">32</xref>,<xref ref-type="bibr" rid="B33-cells-06-00043">33</xref>,<xref ref-type="bibr" rid="B34-cells-06-00043">34</xref>,<xref ref-type="bibr" rid="B35-cells-06-00043">35</xref>,<xref ref-type="bibr" rid="B36-cells-06-00043">36</xref>]. In addition, there was increased radiolabel binding to L-type VGCCs in the brains of Alzheimer’s disease patients post mortem [<xref ref-type="bibr" rid="B37-cells-06-00043">37</xref>]. Along these lines, L-type VGCC activity has been reported to be elevated during aging [<xref ref-type="bibr" rid="B38-cells-06-00043">38</xref>,<xref ref-type="bibr" rid="B39-cells-06-00043">39</xref>] and it is assumed to be involved in age-related alterations of synaptic function [<xref ref-type="bibr" rid="B38-cells-06-00043">38</xref>,<xref ref-type="bibr" rid="B40-cells-06-00043">40</xref>], membrane excitability [<xref ref-type="bibr" rid="B41-cells-06-00043">41</xref>] and cognition [<xref ref-type="bibr" rid="B42-cells-06-00043">42</xref>,<xref ref-type="bibr" rid="B43-cells-06-00043">43</xref>]. Yet, there is some controversy because studies of a mouse model of Alzheimer’s disease rather observed a decrease in L-type VGCC currents, suggesting a complex interplay between several factors including aging, the amount of circulating Aβ, Ca<sup>2+</sup> dysregulation and Ca<sup>2+</sup> release from the endoplasmic reticulum [<xref ref-type="bibr" rid="B44-cells-06-00043">44</xref>].</p>
<p>The continuous interest in using VGCCs as therapeutic targets to treat CNS disorders is also reflected by currently ongoing clinical trials, of which the majority uses L-type calcium channel antagonists. On the one hand, the L-type calcium channel blocker amlodipine is tested in a trial to reduce the risk for Alzheimer’s disease (NCT02913664) and a phase III trial on the use of the L-type calcium channel antagonist nilvadipine to treat Alzheimer’s disease was recently completed (NCT02017340) with results that are still expected. On the other hand, there are ongoing studies on the efficacy of isradipine in early Parkinson’s disease (NCT02168842). Yet, studies in a mouse model of Parkinson’s disease ask for caution since the plasma concentrations of isradipine approved for therapy were not neuroprotective, most likely due to the fact that the drug fails to reduce somatic calcium oscillations of dopaminergic neurons of the substantia nigra [<xref ref-type="bibr" rid="B45-cells-06-00043">45</xref>]. Isradpine is also currently investigated for cognitive enhancement in schizophrenia and schizoaffective disorder (NCT01658150). In addition, the drug is tested for the treatment of nicotine dependence (NCT03083353). There is one trial using the novel drug CX-8998, a T-type VGCC antagonist for the treatment of essential tremor (NCT03101241). Most recently, nimodipine—a Ca<sub>v</sub>1.2 antagonist—was shown to be neuroprotective in the setting of experimental autoimmune encephalomyelitis—the most common animal model for multiple sclerosis—by limiting microglia-mediated damage of the CNS and promoting remyelination [<xref ref-type="bibr" rid="B46-cells-06-00043">46</xref>]. Interestingly, microglia are devoid of the Ca<sub>v</sub>1.2 channel [<xref ref-type="bibr" rid="B46-cells-06-00043">46</xref>] so that the exact mechanism by which nimodipine acts on microglia still has to be elucidated in future studies. <xref ref-type="table" rid="cells-06-00043-t002">Table 2</xref> summarizes hallmark diseases/syndromes and symptoms that are thought to be associated with VGCC involvement.</p>
<p>Overall, several studies regarding the role of VGCCs in CNS pathology exist and several attempts have been made to use VGCC antagonists as therapeutic targets in this context. While historically, VGCCs were targets of the first synthesized drugs [<xref ref-type="bibr" rid="B6-cells-06-00043">6</xref>], the establishment of ion channel-specific therapies for CNS disorders has so far proven to be difficult. Yet, the availability of a broad range of modern technologies such as RNAi, function-blocking antibodies and gene-editing present promising therapeutic avenues, which may be of particular importance for several still incurable and devastating CNS disorders including Alzheimer’s’ and Parkinson’s disease as well as multiple sclerosis.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We would like to thank Ursula Lebherz for critical reading of the manuscript and language revision. We are grateful to Michael Christof for the design of <xref ref-type="fig" rid="cells-06-00043-f001">Figure 1</xref>.</p>
</ack>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<glossary>
<title>Abbreviations</title>
<array orientation="portrait">
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Aβ</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Amyloid β</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">CNS</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Central nervous system</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">HVA</td>
<td align="left" colspan="1" rowspan="1" valign="middle">High-voltage activated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">LVA</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Low-voltage activated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">VGCC</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Voltage-gated calcium channel</td>
</tr>
</tbody>
</array>
</glossary>
<ref-list>
<title>References</title>
<ref id="B1-cells-06-00043">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yagami</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kohma</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yagamoto</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>L-type voltage-dependent calcium channels as therapeutic targets for neurodegenerative diseases</article-title>
<source/>Curr. Med. Chem.
          <year>2012</year>
<volume>19</volume>
<fpage>4816</fpage>
<lpage>4827</lpage>
<pub-id pub-id-type="doi">10.2174/092986712803341430</pub-id>
<pub-id pub-id-type="pmid">22834820</pub-id>
</element-citation>
</ref>
<ref id="B2-cells-06-00043">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braet</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Cabooter</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Paemeleire</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Leybaert</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Calcium signal communication in the central nervous system</article-title>
<source/>Biol. Cell
          <year>2004</year>
<volume>96</volume>
<fpage>79</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1016/j.biolcel.2003.10.007</pub-id>
<pub-id pub-id-type="pmid">15093130</pub-id>
</element-citation>
</ref>
<ref id="B3-cells-06-00043">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Role of calcium in central nervous system injuries</article-title>
<source/>J. Neurotrauma
          <year>1992</year>
<volume>9</volume>
<issue>Suppl. S1</issue>
<fpage>S9</fpage>
<lpage>S25</lpage>
<pub-id pub-id-type="pmid">1588635</pub-id>
</element-citation>
</ref>
<ref id="B4-cells-06-00043">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Catterall</surname>
<given-names>W.A.</given-names>
</name>
<name>
<surname>Perez-Reyes</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Snutch</surname>
<given-names>T.P.</given-names>
</name>
<name>
<surname>Striessnig</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels</article-title>
<source/>Pharmacol. Rev.
          <year>2005</year>
<volume>57</volume>
<fpage>411</fpage>
<lpage>425</lpage>
<pub-id pub-id-type="doi">10.1124/pr.57.4.5</pub-id>
<pub-id pub-id-type="pmid">16382099</pub-id>
</element-citation>
</ref>
<ref id="B5-cells-06-00043">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wormuth</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lundt</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Henseler</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Müller</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Broich</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Papazoglou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Weiergräber</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Ca<sub>v</sub>2.3 R-type voltage-gated Ca<sup>2+</sup> channels—Functional implications in convulsive and non-convulsive seizure activity</article-title>
<source/>Open Neurol. J.
          <year>2016</year>
<volume>10</volume>
<fpage>99</fpage>
<lpage>126</lpage>
<pub-id pub-id-type="doi">10.2174/1874205X01610010099</pub-id>
<pub-id pub-id-type="pmid">27843503</pub-id>
</element-citation>
</ref>
<ref id="B6-cells-06-00043">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waszkielewicz</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Gunia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Szkaradek</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Słoczyńska</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Krupińska</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Marona</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Ion channels as drug targets in central nervous system disorders</article-title>
<source/>Curr. Med. Chem.
          <year>2013</year>
<volume>20</volume>
<fpage>1241</fpage>
<lpage>1285</lpage>
<pub-id pub-id-type="doi">10.2174/0929867311320100005</pub-id>
<pub-id pub-id-type="pmid">23409712</pub-id>
</element-citation>
</ref>
<ref id="B7-cells-06-00043">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schlick</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Flucher</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Obermair</surname>
<given-names>G.J.</given-names>
</name>
</person-group>
<article-title>Voltage-activated calcium channel expression profiles in mouse brain and cultured hippocampal neurons</article-title>
<source/>Neuroscience
          <year>2010</year>
<volume>167</volume>
<fpage>786</fpage>
<lpage>798</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.02.037</pub-id>
<pub-id pub-id-type="pmid">20188150</pub-id>
</element-citation>
</ref>
<ref id="B8-cells-06-00043">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verkhratsky</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kettenmann</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Calcium signalling in glial cells</article-title>
<source/>Trends Neurosci.
          <year>1996</year>
<volume>19</volume>
<fpage>346</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="doi">10.1016/0166-2236(96)10048-5</pub-id>
<pub-id pub-id-type="pmid">8843604</pub-id>
</element-citation>
</ref>
<ref id="B9-cells-06-00043">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casamassima</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hay</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Benedetti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lattanzi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cassano</surname>
<given-names>G.B.</given-names>
</name>
<name>
<surname>Perlis</surname>
<given-names>R.H.</given-names>
</name>
</person-group>
<article-title>L-type calcium channels and psychiatric disorders: A brief review</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
          <year>2010</year>
<volume>153B</volume>
<fpage>1373</fpage>
<lpage>1390</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.31122</pub-id>
<pub-id pub-id-type="pmid">20886543</pub-id>
</element-citation>
</ref>
<ref id="B10-cells-06-00043">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Triggle</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>Calcium channel antagonists: Clinical uses—Past, present and future</article-title>
<source/>Biochem. Pharmacol.
          <year>2007</year>
<volume>74</volume>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.bcp.2007.01.016</pub-id>
<pub-id pub-id-type="pmid">17276408</pub-id>
</element-citation>
</ref>
<ref id="B11-cells-06-00043">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silei</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Fabrizi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Venturini</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Salmona</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bugiani</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Tagliavini</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lauro</surname>
<given-names>G.M.</given-names>
</name>
</person-group>
<article-title>Activation of microglial cells by PrP and beta-amyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channels</article-title>
<source/>Brain Res.
          <year>1999</year>
<volume>818</volume>
<fpage>168</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(98)01272-4</pub-id>
<pub-id pub-id-type="pmid">9914452</pub-id>
</element-citation>
</ref>
<ref id="B12-cells-06-00043">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seitter</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Koschak</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Relevance of tissue specific subunit expression in channelopathies</article-title>
<source/>Neuropharmacology
          <year>2017</year>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2017.06.029</pub-id>
<pub-id pub-id-type="pmid">28669898</pub-id>
</element-citation>
</ref>
<ref id="B13-cells-06-00043">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lyubchenko</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Ca<sup>2+</sup> signalling in B cells</article-title>
<source/>Sci. World J.
          <year>2010</year>
<volume>10</volume>
<fpage>2254</fpage>
<lpage>2264</lpage>
<pub-id pub-id-type="doi">10.1100/tsw.2010.219</pub-id>
<pub-id pub-id-type="pmid">21103794</pub-id>
</element-citation>
</ref>
<ref id="B14-cells-06-00043">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sadighi Akha</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Willmott</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Brickley</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dolphin</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Galione</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hunt</surname>
<given-names>S.V.</given-names>
</name>
</person-group>
<article-title>Anti-Ig-induced calcium influx in rat B lymphocytes mediated by cGMP through a dihydropyridine-sensitive channel</article-title>
<source/>J. Biol. Chem.
          <year>1996</year>
<volume>13</volume>
<fpage>7297</fpage>
<lpage>7300</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.271.13.7297</pub-id>
</element-citation>
</ref>
<ref id="B15-cells-06-00043">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mesirca</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Torrente</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Mangoni</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>Functional role of voltage gated Ca(<sup>2+</sup>) channels in heart automaticity</article-title>
<source/>Front. Physiol.
          <year>2015</year>
<volume>6</volume>
<fpage>19</fpage>
<pub-id pub-id-type="doi">10.3389/fphys.2015.00019</pub-id>
<pub-id pub-id-type="pmid">25698974</pub-id>
</element-citation>
</ref>
<ref id="B16-cells-06-00043">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stys</surname>
<given-names>P.K.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Calpain-dependent neurofilament breakdown in anoxic and ischemic rat central axons</article-title>
<source/>Neurosci. Lett.
          <year>2002</year>
<volume>328</volume>
<fpage>150</fpage>
<lpage>154</lpage>
<pub-id pub-id-type="doi">10.1016/S0304-3940(02)00469-X</pub-id>
<pub-id pub-id-type="pmid">12133577</pub-id>
</element-citation>
</ref>
<ref id="B17-cells-06-00043">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takano</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ohguro</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dezawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ohguro</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Mamiya</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Metoki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Nakazawa</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Study of drug effects of calcium channel blockers on retinal degeneration of rd mouse</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>2004</year>
<volume>313</volume>
<fpage>1015</fpage>
<lpage>1022</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2003.12.034</pub-id>
<pub-id pub-id-type="pmid">14706644</pub-id>
</element-citation>
</ref>
<ref id="B18-cells-06-00043">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Damaj</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>B.R.</given-names>
</name>
</person-group>
<article-title>Calcium agonists and antagonists of the dihydropyridine type: Effect on nicotine-induced antinociception and hypomotility</article-title>
<source/>Drug Alcohol Depend.
          <year>1993</year>
<volume>32</volume>
<fpage>73</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="doi">10.1016/0376-8716(93)90024-K</pub-id>
<pub-id pub-id-type="pmid">7683598</pub-id>
</element-citation>
</ref>
<ref id="B19-cells-06-00043">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonsette</surname>
<given-names>R.E.</given-names>
</name>
</person-group>
<article-title>Oxidative stress and excitotoxicity: A therapeutic issue in multiple sclerosis?</article-title>
<source/>Mult. Scler. J.
          <year>2008</year>
<volume>14</volume>
<fpage>22</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1177/1352458507080111</pub-id>
<pub-id pub-id-type="pmid">17881394</pub-id>
</element-citation>
</ref>
<ref id="B20-cells-06-00043">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waxman</surname>
<given-names>S.G.</given-names>
</name>
</person-group>
<article-title>Axonal conduction and injury in multiple sclerosis: The role of sodium channels</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2006</year>
<volume>7</volume>
<fpage>932</fpage>
<lpage>941</lpage>
<pub-id pub-id-type="doi">10.1038/nrn2023</pub-id>
<pub-id pub-id-type="pmid">17115075</pub-id>
</element-citation>
</ref>
<ref id="B21-cells-06-00043">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zambonin</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ohno</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>G.R.</given-names>
</name>
<name>
<surname>Engeham</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ziabreva</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Schwarz</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Frischer</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Turnbull</surname>
<given-names>D.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased mitochondrial content in remyelinated axons: Implications for multiple sclerosis</article-title>
<source/>Brain
          <year>2011</year>
<volume>134</volume>
<fpage>1901</fpage>
<lpage>1913</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awr110</pub-id>
<pub-id pub-id-type="pmid">21705418</pub-id>
</element-citation>
</ref>
<ref id="B22-cells-06-00043">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhib-Jalbut</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Cleveland</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Friedlander</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Mouradian</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Przedborski</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Trapp</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Wyss-Coray</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yong</surname>
<given-names>V.W.</given-names>
</name>
</person-group>
<article-title>Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases</article-title>
<source/>J. Neuroimmunol.
          <year>2006</year>
<volume>176</volume>
<fpage>198</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneuroim.2006.03.027</pub-id>
<pub-id pub-id-type="pmid">16983747</pub-id>
</element-citation>
</ref>
<ref id="B23-cells-06-00043">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dutta</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>McDonough</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Torres</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gudz</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Macklin</surname>
<given-names>W.B.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>R.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients</article-title>
<source/>Ann. Neurol.
          <year>2006</year>
<volume>59</volume>
<fpage>478</fpage>
<lpage>489</lpage>
<pub-id pub-id-type="doi">10.1002/ana.20736</pub-id>
<pub-id pub-id-type="pmid">16392116</pub-id>
</element-citation>
</ref>
<ref id="B24-cells-06-00043">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trump</surname>
<given-names>B.F.</given-names>
</name>
<name>
<surname>Berezesky</surname>
<given-names>I.K.</given-names>
</name>
</person-group>
<article-title>Calcium-mediated cell injury and cell death</article-title>
<source/>FASEB J.
          <year>1995</year>
<volume>9</volume>
<fpage>219</fpage>
<lpage>228</lpage>
<pub-id pub-id-type="pmid">7781924</pub-id>
</element-citation>
</ref>
<ref id="B25-cells-06-00043">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soellner</surname>
<given-names>I.A.</given-names>
</name>
<name>
<surname>Rabe</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mauri</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Addicks</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kuerten</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Differential aspects of immune cell infiltration and neurodegeneration in acute and relapse experimental autoimmune encephalomyelitis</article-title>
<source/>Clin. Immunol.
          <year>2013</year>
<volume>149</volume>
<fpage>519</fpage>
<lpage>529</lpage>
<pub-id pub-id-type="doi">10.1016/j.clim.2013.10.011</pub-id>
<pub-id pub-id-type="pmid">24239839</pub-id>
</element-citation>
</ref>
<ref id="B26-cells-06-00043">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heyes</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pratt</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Rees</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dahimene</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ferron</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Dolphin</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders</article-title>
<source/>Prog. Neurobiol.
          <year>2015</year>
<volume>134</volume>
<fpage>36</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1016/j.pneurobio.2015.09.002</pub-id>
<pub-id pub-id-type="pmid">26386135</pub-id>
</element-citation>
</ref>
<ref id="B27-cells-06-00043">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ritz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rhodes</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Schernhammer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Olsen</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Friis</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>L-type calcium channel blockers and Parkinson disease in Denmark</article-title>
<source/>Ann. Neurol.
          <year>2010</year>
<volume>67</volume>
<fpage>600</fpage>
<lpage>606</lpage>
<pub-id pub-id-type="doi">10.1002/ana.21937</pub-id>
<pub-id pub-id-type="pmid">20437557</pub-id>
</element-citation>
</ref>
<ref id="B28-cells-06-00043">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Surmeier</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Schumacker</surname>
<given-names>P.T.</given-names>
</name>
<name>
<surname>Guzman</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Ilijic</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zampese</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Calcium and Parkinson’s disease</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>2017</year>
<volume>483</volume>
<fpage>1013</fpage>
<lpage>1019</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2016.08.168</pub-id>
<pub-id pub-id-type="pmid">27590583</pub-id>
</element-citation>
</ref>
<ref id="B29-cells-06-00043">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davidson</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Shajenko</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Donta</surname>
<given-names>T.S.</given-names>
</name>
</person-group>
<article-title>Amyloid beta-peptide (A beta P) potentiates a nimodipine-sensitive L-type barium conductance in N1E-115 neuroblastoma cells</article-title>
<source/>Brain Res.
          <year>1994</year>
<volume>643</volume>
<fpage>324</fpage>
<lpage>327</lpage>
<pub-id pub-id-type="doi">10.1016/0006-8993(94)90041-8</pub-id>
<pub-id pub-id-type="pmid">7518331</pub-id>
</element-citation>
</ref>
<ref id="B30-cells-06-00043">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>N.T.</given-names>
</name>
<name>
<surname>Kan</surname>
<given-names>K.K.</given-names>
</name>
<name>
<surname>Tsang</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>Tsim</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bis(7)-tacrine attenuates beta amyloid-induced neuronal apoptosis by regulating L-type calcium channels</article-title>
<source/>J. Neurochem.
          <year>2006</year>
<volume>98</volume>
<fpage>1400</fpage>
<lpage>1410</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2006.03960.x</pub-id>
<pub-id pub-id-type="pmid">16771827</pub-id>
</element-citation>
</ref>
<ref id="B31-cells-06-00043">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rhim</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Effects of amyloid-beta peptides on voltage-gated L-type Ca(V)1.2 and Ca(V)1.3 Ca (<sup>2+</sup>) channels</article-title>
<source/>Mol. Cells
          <year>2011</year>
<volume>32</volume>
<fpage>289</fpage>
<lpage>294</lpage>
<pub-id pub-id-type="doi">10.1007/s10059-011-0075-x</pub-id>
<pub-id pub-id-type="pmid">21822937</pub-id>
</element-citation>
</ref>
<ref id="B32-cells-06-00043">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramsden</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Henderson</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Pearson</surname>
<given-names>H.A.</given-names>
</name>
</person-group>
<article-title>Modulation of Ca<sup>2+</sup> channel currents in primary cultures of rat cortical neurones by amyloid beta protein (1–40) is dependent on solubility status</article-title>
<source/>Brain Res.
          <year>2002</year>
<volume>956</volume>
<fpage>254</fpage>
<lpage>261</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(02)03547-3</pub-id>
<pub-id pub-id-type="pmid">12445693</pub-id>
</element-citation>
</ref>
<ref id="B33-cells-06-00043">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scragg</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Fearon</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Boyle</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Varadi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Peers</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Alzheimer’s amyloid peptides mediate hypoxic up-regulation of L-type Ca<sup>2+</sup> channels</article-title>
<source/>FASEB J.
          <year>2005</year>
<volume>19</volume>
<fpage>150</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="doi">10.1096/fj.04-2659fje</pub-id>
<pub-id pub-id-type="pmid">15494446</pub-id>
</element-citation>
</ref>
<ref id="B34-cells-06-00043">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ueda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shinohara</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yagami</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Asakura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kawasaki</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Amyloid beta protein potentiates Ca<sup>2+</sup> influx through L-type voltage-sensitive Ca<sup>2+</sup> channels: A possible involvement of free radicals</article-title>
<source/>J. Neurochem.
          <year>1997</year>
<volume>68</volume>
<fpage>265</fpage>
<lpage>271</lpage>
<pub-id pub-id-type="doi">10.1046/j.1471-4159.1997.68010265.x</pub-id>
<pub-id pub-id-type="pmid">8978734</pub-id>
</element-citation>
</ref>
<ref id="B35-cells-06-00043">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Webster</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Ramsden</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Boyle</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Pearson</surname>
<given-names>H.A.</given-names>
</name>
<name>
<surname>Peers</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Amyloid peptides mediate hypoxic increase of L-type Ca<sup>2+</sup> channels in central neurons</article-title>
<source/>Neurobiol. Aging
          <year>2006</year>
<volume>27</volume>
<fpage>439</fpage>
<lpage>445</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2005.02.002</pub-id>
<pub-id pub-id-type="pmid">16464656</pub-id>
</element-citation>
</ref>
<ref id="B36-cells-06-00043">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiss</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Pike</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Cotman</surname>
<given-names>C.W.</given-names>
</name>
</person-group>
<article-title>Ca<sup>2+</sup> channel blockers attenuate beta-amyloid peptide toxicity to cortical neurons in culture</article-title>
<source/>J. Neurochem.
          <year>1994</year>
<volume>62</volume>
<fpage>372</fpage>
<lpage>375</lpage>
<pub-id pub-id-type="doi">10.1046/j.1471-4159.1994.62010372.x</pub-id>
<pub-id pub-id-type="pmid">8263540</pub-id>
</element-citation>
</ref>
<ref id="B37-cells-06-00043">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coon</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Mactutus</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Booze</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>L-type calcium channels in the hippocampus and cerebellum of Alzheimer’s disease brain tissue</article-title>
<source/>Neurobiol. Aging
          <year>1999</year>
<volume>20</volume>
<fpage>597</fpage>
<lpage>603</lpage>
<pub-id pub-id-type="doi">10.1016/S0197-4580(99)00068-8</pub-id>
<pub-id pub-id-type="pmid">10674425</pub-id>
</element-citation>
</ref>
<ref id="B38-cells-06-00043">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thibault</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Landfield</surname>
<given-names>P.W.</given-names>
</name>
</person-group>
<article-title>Increase in single L-type calcium channels in hippocampal neurons during aging</article-title>
<source/>Science
          <year>1996</year>
<volume>272</volume>
<fpage>1017</fpage>
<lpage>1020</lpage>
<pub-id pub-id-type="doi">10.1126/science.272.5264.1017</pub-id>
<pub-id pub-id-type="pmid">8638124</pub-id>
</element-citation>
</ref>
<ref id="B39-cells-06-00043">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Norris</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Blalock</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K.C.</given-names>
</name>
<name>
<surname>Porter</surname>
<given-names>N.M.</given-names>
</name>
<name>
<surname>Thibault</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Kraner</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Landfield</surname>
<given-names>P.W.</given-names>
</name>
</person-group>
<article-title>Hippocampal ‘zipper’ slice studies reveal a necessary role for calcineurin in the increased activity of L-type Ca(<sup>2+</sup>) channels with aging</article-title>
<source/>Neurobiol. Aging
          <year>2010</year>
<volume>31</volume>
<fpage>328</fpage>
<lpage>338</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2008.03.026</pub-id>
<pub-id pub-id-type="pmid">18471936</pub-id>
</element-citation>
</ref>
<ref id="B40-cells-06-00043">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Norris</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Halpain</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Reversal of age-related alterations in synaptic plasticity by blockade of L-type Ca<sup>2+</sup> channels</article-title>
<source/>J. Neurosci.
          <year>1998</year>
<volume>18</volume>
<fpage>3171</fpage>
<lpage>3179</lpage>
<pub-id pub-id-type="pmid">9547225</pub-id>
</element-citation>
</ref>
<ref id="B41-cells-06-00043">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moyer</surname>
<given-names>J.R.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Thompson</surname>
<given-names>L.T.</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Disterhoft</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>Nimodipine increases excitability of rabbit CA1 pyramidal neurons in an age- and concentration-dependent manner</article-title>
<source/>J. Neurophysiol.
          <year>1992</year>
<volume>68</volume>
<fpage>2100</fpage>
<lpage>2109</lpage>
<pub-id pub-id-type="pmid">1491260</pub-id>
</element-citation>
</ref>
<ref id="B42-cells-06-00043">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deyo</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Straube</surname>
<given-names>K.T.</given-names>
</name>
<name>
<surname>Disterhoft</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>Nimodipine facilitates associative learning in aging rabbits</article-title>
<source/>Science
          <year>1989</year>
<volume>243</volume>
<fpage>809</fpage>
<lpage>811</lpage>
<pub-id pub-id-type="doi">10.1126/science.2916127</pub-id>
<pub-id pub-id-type="pmid">2916127</pub-id>
</element-citation>
</ref>
<ref id="B43-cells-06-00043">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veng</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Mesches</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Browning</surname>
<given-names>M.D.</given-names>
</name>
</person-group>
<article-title>Age-related working memory impairment is correlated with increases in the L-type calcium channel protein alpha1D (Cav1.3) in area CA1 of the hippocampus and both are ameliorated by chronic nimodipine treatment</article-title>
<source/>Brain Res. Mol. Brain Res.
          <year>2003</year>
<volume>110</volume>
<fpage>193</fpage>
<lpage>202</lpage>
<pub-id pub-id-type="doi">10.1016/S0169-328X(02)00643-5</pub-id>
<pub-id pub-id-type="pmid">12591156</pub-id>
</element-citation>
</ref>
<ref id="B44-cells-06-00043">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thibault</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Pancani</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Landfield</surname>
<given-names>P.W.</given-names>
</name>
<name>
<surname>Norris</surname>
<given-names>C.M.</given-names>
</name>
</person-group>
<article-title>Reduction in neuronal L-type calcium channel activity in a double knock-in mouse model of Alzheimer’s disease</article-title>
<source/>Biochim. Biophys. Acta
          <year>2012</year>
<volume>1822</volume>
<fpage>546</fpage>
<lpage>549</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbadis.2012.01.004</pub-id>
<pub-id pub-id-type="pmid">22265986</pub-id>
</element-citation>
</ref>
<ref id="B45-cells-06-00043">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ortner</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Bock</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Dougalis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kharitonova</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Duda</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hess</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tuluc</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pomberger</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Stefanova</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Pitterl</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lower affinity of isradipine for L-Type Ca<sup>2+</sup> channels during substantia nigra dopamine neuron-like activity: Implications for neuroprotection in Parkinson's disease</article-title>
<source/>J. Neurosci.
          <year>2017</year>
<volume>37</volume>
<fpage>6761</fpage>
<lpage>6777</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2946-16.2017</pub-id>
<pub-id pub-id-type="pmid">28592699</pub-id>
</element-citation>
</ref>
<ref id="B46-cells-06-00043">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schampel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Volovitch</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Koeniger</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Scholz</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Jörg</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Linker</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Wischmeyer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wunsch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hell</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Ergün</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2017</year>
<volume>114</volume>
<fpage>E3295</fpage>
<lpage>E3304</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1620052114</pub-id>
<pub-id pub-id-type="pmid">28381594</pub-id>
</element-citation>
</ref>
<ref id="B47-cells-06-00043">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Splawski</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Timothy</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Decher</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sachse</surname>
<given-names>F.B.</given-names>
</name>
<name>
<surname>Beggs</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Sanguinetti</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Keating</surname>
<given-names>M.T.</given-names>
</name>
</person-group>
<article-title>Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2005</year>
<volume>102</volume>
<fpage>8089</fpage>
<lpage>8096</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0502506102</pub-id>
<pub-id pub-id-type="pmid">15863612</pub-id>
</element-citation>
</ref>
<ref id="B48-cells-06-00043">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Busquet</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hetzenauer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sinnegger-Brauns</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Striessnig</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Singewald</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Role of L-type Ca<sup>2+</sup> channel isoforms in the extinction of conditioned fear</article-title>
<source/>Learn. Mem.
          <year>2008</year>
<volume>15</volume>
<fpage>378</fpage>
<lpage>386</lpage>
<pub-id pub-id-type="doi">10.1101/lm.886208</pub-id>
<pub-id pub-id-type="pmid">18441296</pub-id>
</element-citation>
</ref>
<ref id="B49-cells-06-00043">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dao</surname>
<given-names>D.T.</given-names>
</name>
<name>
<surname>Mahon</surname>
<given-names>P.B.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Kovacsics</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Blackwell</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Arad</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zandi</surname>
<given-names>P.P.</given-names>
</name>
<name>
<surname>O’Donnell</surname>
<given-names>P.</given-names>
</name>
<collab>Bipolar Genome Study (BiGS) Consortium</collab>
<etal></etal>
</person-group>
<article-title>Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans</article-title>
<source/>Biol. Psychiatry
          <year>2010</year>
<volume>68</volume>
<fpage>801</fpage>
<lpage>810</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2010.06.019</pub-id>
<pub-id pub-id-type="pmid">20723887</pub-id>
</element-citation>
</ref>
<ref id="B50-cells-06-00043">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ostacher</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Iosifescu</surname>
<given-names>D.V.</given-names>
</name>
<name>
<surname>Hay</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Blumenthal</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Sklar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Perlis</surname>
<given-names>R.H.</given-names>
</name>
</person-group>
<article-title>Pilot investigation of isradipine in the treatment of bipolar depression motivated by genome-wide association</article-title>
<source/>Bipolar Disord.
          <year>2014</year>
<volume>16</volume>
<fpage>199</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1111/bdi.12143</pub-id>
<pub-id pub-id-type="pmid">24372835</pub-id>
</element-citation>
</ref>
<ref id="B51-cells-06-00043">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Radzicki</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yau</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Pollema-Mays</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Mlsna</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Martina</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Temperature-sensitive Cav1.2 calcium channels support intrinsic firing of pyramidal neurons and provide a target for the treatment of febrile seizures</article-title>
<source/>J. Neurosci.
          <year>2013</year>
<volume>33</volume>
<fpage>9920</fpage>
<lpage>9931</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5482-12.2013</pub-id>
<pub-id pub-id-type="pmid">23761887</pub-id>
</element-citation>
</ref>
<ref id="B52-cells-06-00043">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roca-Lapirot</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Radwani</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Aby</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Nagy</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Landry</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fossat</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Calcium signalling through L-type calcium channels: Role in pathophysiology of spinal nociceptive transmission</article-title>
<source/>Br. J. Pharmacol.
          <year>2017</year>
<pub-id pub-id-type="doi">10.1111/bph.13747</pub-id>
<pub-id pub-id-type="pmid">28214378</pub-id>
</element-citation>
</ref>
<ref id="B53-cells-06-00043">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Radwani</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lopez-Gonzalez</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Cattaert</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Roca-Lapirot</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Dobremez</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bouali-Benazzouz</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Eiríksdóttir</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Langel</surname>
<given-names>Ü.</given-names>
</name>
<name>
<surname>Favereaux</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Errami</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ca<sub>v</sub>1.2 and Ca<sub>v</sub>1.3 L-type calcium channels independently control short- and long-term sensitization to pain</article-title>
<source/>J. Physiol.
          <year>2016</year>
<volume>594</volume>
<fpage>6607</fpage>
<lpage>6626</lpage>
<pub-id pub-id-type="doi">10.1113/JP272725</pub-id>
<pub-id pub-id-type="pmid">27231046</pub-id>
</element-citation>
</ref>
<ref id="B54-cells-06-00043">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gadotti</surname>
<given-names>V.M.</given-names>
</name>
<name>
<surname>Bladen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F.X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gündüz</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Simsek</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Safak</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zamponi</surname>
<given-names>G.W.</given-names>
</name>
</person-group>
<article-title>Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels</article-title>
<source/>Pflugers Arch.
          <year>2015</year>
<volume>467</volume>
<fpage>2485</fpage>
<lpage>2493</lpage>
<pub-id pub-id-type="doi">10.1007/s00424-015-1725-1</pub-id>
<pub-id pub-id-type="pmid">26286466</pub-id>
</element-citation>
</ref>
<ref id="B55-cells-06-00043">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ripke</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>O’Dushlaine</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chambert</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Moran</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Kahler</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Akterin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bergen</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Crowley</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Fromer</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide association analysis identifies 13 new risk loci for schizophrenia</article-title>
<source/>Nat. Genet.
          <year>2013</year>
<volume>45</volume>
<fpage>1150</fpage>
<lpage>1159</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2742</pub-id>
<pub-id pub-id-type="pmid">23974872</pub-id>
</element-citation>
</ref>
<ref id="B56-cells-06-00043">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nouvian</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Beutner</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Parsons</surname>
<given-names>T.D.</given-names>
</name>
<name>
<surname>Moser</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Structure and function of the hair cell ribbon synapse</article-title>
<source/>J. Membr. Biol.
          <year>2006</year>
<volume>209</volume>
<fpage>153</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="doi">10.1007/s00232-005-0854-4</pub-id>
<pub-id pub-id-type="pmid">16773499</pub-id>
</element-citation>
</ref>
<ref id="B57-cells-06-00043">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Platzer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Engel</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schrott-Fischer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stephan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bova</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Striessnig</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca<sup>2+</sup> channels</article-title>
<source/>Cell
          <year>2000</year>
<volume>102</volume>
<fpage>89</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)00013-1</pub-id>
<pub-id pub-id-type="pmid">10929716</pub-id>
</element-citation>
</ref>
<ref id="B58-cells-06-00043">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orthner</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Striessnig</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>L-type calcium channels as drug targets in CNS disorders</article-title>
<source/>Channels
          <year>2016</year>
<volume>10</volume>
<fpage>7</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1080/19336950.2015.1048936</pub-id>
<pub-id pub-id-type="pmid">26039257</pub-id>
</element-citation>
</ref>
<ref id="B59-cells-06-00043">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Striessnig</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hoda</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Koschak</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zaghetto</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Müllner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sinnegger-Brauns</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Wild</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Watschinger</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Trockenbacher</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pelster</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>L-type Ca<sup>2+</sup> channels in Ca<sup>2+</sup> channelopathies</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>2004</year>
<volume>322</volume>
<fpage>1341</fpage>
<lpage>1346</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2004.08.039</pub-id>
<pub-id pub-id-type="pmid">15336981</pub-id>
</element-citation>
</ref>
<ref id="B60-cells-06-00043">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bech-Hansen</surname>
<given-names>N.T.</given-names>
</name>
<name>
<surname>Naylor</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Maybaum</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Pearce</surname>
<given-names>W.G.</given-names>
</name>
<name>
<surname>Koop</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Fishman</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Mets</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Musarella</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Boycott</surname>
<given-names>K.M.</given-names>
</name>
</person-group>
<article-title>Loss-of-function mutations in a calcium-channel α1 subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness</article-title>
<source/>Nat. Genet.
          <year>1998</year>
<volume>19</volume>
<fpage>264</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1038/947</pub-id>
<pub-id pub-id-type="pmid">9662400</pub-id>
</element-citation>
</ref>
<ref id="B61-cells-06-00043">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nachbauer</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Nocker</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Karner</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Stankovic</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Unterberger</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Eigentler</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Poewe</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Delazer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Boesch</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Episodic ataxia type 2: Phenotype characteristics of a novel CACNA1A mutation and review of the literature</article-title>
<source/>J. Neurol.
          <year>2014</year>
<volume>261</volume>
<fpage>983</fpage>
<lpage>991</lpage>
<pub-id pub-id-type="doi">10.1007/s00415-014-7310-2</pub-id>
<pub-id pub-id-type="pmid">24658662</pub-id>
</element-citation>
</ref>
<ref id="B62-cells-06-00043">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baloh</surname>
<given-names>R.W.</given-names>
</name>
<name>
<surname>Jen</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Genetics of familial episodic vertigo and ataxia</article-title>
<source/>Ann. N. Y. Acad. Sci.
          <year>2002</year>
<volume>956</volume>
<fpage>338</fpage>
<lpage>345</lpage>
<pub-id pub-id-type="doi">10.1111/j.1749-6632.2002.tb02832.x</pub-id>
<pub-id pub-id-type="pmid">11960817</pub-id>
</element-citation>
</ref>
<ref id="B63-cells-06-00043">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van den Maagdenberg</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Pietrobon</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pizzorusso</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kaja</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Broos</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Cesetti</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>van den Ven</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Tottene</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>van der Kaa</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Plomp</surname>
<given-names>J.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression</article-title>
<source/>Neuron
          <year>2004</year>
<volume>41</volume>
<fpage>701</fpage>
<lpage>710</lpage>
<pub-id pub-id-type="doi">10.1016/S0896-6273(04)00085-6</pub-id>
<pub-id pub-id-type="pmid">15003170</pub-id>
</element-citation>
</ref>
<ref id="B64-cells-06-00043">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsuyama</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Kawakami</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Maruyama</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Izumi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Komure</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Udaka</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kameyama</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nishio</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kuroda</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular features of the CAG repeats of spinocerebellar ataxia 6 (SCA6)</article-title>
<source/>Hum. Mol. Genet.
          <year>1997</year>
<volume>6</volume>
<fpage>1283</fpage>
<lpage>1287</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/6.8.1283</pub-id>
<pub-id pub-id-type="pmid">9259274</pub-id>
</element-citation>
</ref>
<ref id="B65-cells-06-00043">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhuchenko</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bonnen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ashizawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Stockton</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Amos</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dobyns</surname>
<given-names>W.B.</given-names>
</name>
<name>
<surname>Subramony</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C.C.</given-names>
</name>
</person-group>
<article-title>Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel</article-title>
<source/>Nat. Genet.
          <year>1997</year>
<volume>15</volume>
<fpage>62</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="doi">10.1038/ng0197-62</pub-id>
<pub-id pub-id-type="pmid">8988170</pub-id>
</element-citation>
</ref>
<ref id="B66-cells-06-00043">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaman</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Paydar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Cheong</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>H.S.</given-names>
</name>
</person-group>
<article-title>Ca<sub>v</sub>2.3 channels are critical for oscillatory burst discharges in the reticular thalamus and absence epilepsy</article-title>
<source/>Neuron
          <year>2011</year>
<volume>70</volume>
<fpage>95</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2011.02.042</pub-id>
<pub-id pub-id-type="pmid">21482359</pub-id>
</element-citation>
</ref>
<ref id="B67-cells-06-00043">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saegusa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kurihara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Minowa</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Kazuno</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Matsuda</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yamanaka</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Osanai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Noda</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered pain responses in mice lacking α1E subunit of the voltage-dependent Ca<sup>2+</sup> channel</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2000</year>
<volume>97</volume>
<fpage>6132</fpage>
<lpage>6137</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.100124197</pub-id>
<pub-id pub-id-type="pmid">10801976</pub-id>
</element-citation>
</ref>
<ref id="B68-cells-06-00043">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ernst</surname>
<given-names>W.L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Ernst</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Noebels</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Genetic enhancement of thalamocortical network activity by elevating α1G-mediated low-voltage-activated calcium current induces pure absence epilepsy</article-title>
<source/>J. Neurosci.
          <year>2009</year>
<volume>29</volume>
<fpage>1615</fpage>
<lpage>1625</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2081-08.2009</pub-id>
<pub-id pub-id-type="pmid">19211869</pub-id>
</element-citation>
</ref>
<ref id="B69-cells-06-00043">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Martinez-Agosto</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Cantor</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>Support for calcium channel gene defects in autism spectrum disorders</article-title>
<source/>Mol. Autism
          <year>2012</year>
<volume>3</volume>
<fpage>18</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-3-18</pub-id>
<pub-id pub-id-type="pmid">23241247</pub-id>
</element-citation>
</ref>
<ref id="B70-cells-06-00043">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bourinet</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Francois</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Laffray</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>T-type channels in neuropathic pain</article-title>
<source/>Pain
          <year>2016</year>
<volume>127</volume>
<issue>Suppl. S1</issue>
<fpage>S15</fpage>
<lpage>S22</lpage>
<pub-id pub-id-type="doi">10.1097/j.pain.0000000000000469</pub-id>
<pub-id pub-id-type="pmid">26785151</pub-id>
</element-citation>
</ref>
<ref id="B71-cells-06-00043">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tai</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.C.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>C.C.</given-names>
</name>
</person-group>
<article-title>Modulation of subthalamic T-type Ca<sup>2+</sup> channels remedies locomotor deficits in a rat model of Parkinson disease</article-title>
<source/>J. Clin. Investig.
          <year>2011</year>
<volume>121</volume>
<fpage>3289</fpage>
<lpage>3305</lpage>
<pub-id pub-id-type="doi">10.1172/JCI46482</pub-id>
<pub-id pub-id-type="pmid">21737877</pub-id>
</element-citation>
</ref>
<ref id="B72-cells-06-00043">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nimrich</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Eckert</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Calcium channel blockers and dementia</article-title>
<source/>Br. J. Pharmacol.
          <year>2013</year>
<volume>169</volume>
<fpage>1203</fpage>
<lpage>1210</lpage>
<pub-id pub-id-type="doi">10.1111/bph.12240</pub-id>
<pub-id pub-id-type="pmid">23638877</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="cells-06-00043-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Distribution of VGCC subtypes on different cell types.</p>
</caption>
<graphic xlink:href="cells-06-00043-g001"></graphic>
</fig>
<table-wrap id="cells-06-00043-t001" orientation="portrait" position="float">
<object-id pub-id-type="pii">cells-06-00043-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>Classification of voltage-gated calcium channels (VGCCs) according to their voltage-dependent activation.</p>
</caption>
<table frame="hsides" rules="groups">
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">
<bold>High-Voltage Activated</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">
<bold>Family</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">L-type (“long-lasting”) VGCC</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Ca<sub>v</sub>1.1–Ca<sub>v</sub>1.4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">P-type (“Purkinje cell”)/Q-type VGCC</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Ca<sub>v</sub>2.1</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">N-type (“neural”) VGCC</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Ca<sub>v</sub>2.2</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">R-type (“residual”/“resistant”) VGCC</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Ca<sub>v</sub>2.3</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Low-Voltage Activated</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Family</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">T-type (“transient”) VGCC</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Ca<sub>v</sub>3.1–Ca<sub>v</sub>3.3</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="cells-06-00043-t002" orientation="portrait" position="float">
<object-id pub-id-type="pii">cells-06-00043-t002_Table 2</object-id>
<label>Table 2</label>
<caption>
<p>Involvement of VGCCs in neurologic and psychiatric disorders.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Channel</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Disease/Symptom</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Species</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="8" style="border-bottom:solid thin" valign="middle">Ca<sub>v</sub>1.2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Autism/Timothy syndrome</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Human [<xref ref-type="bibr" rid="B47-cells-06-00043">47</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Conditioned fear</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Mouse [<xref ref-type="bibr" rid="B48-cells-06-00043">48</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Depression/Mood disorders</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Human, mouse [<xref ref-type="bibr" rid="B49-cells-06-00043">49</xref>,<xref ref-type="bibr" rid="B50-cells-06-00043">50</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Febrile seizures</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Rat [<xref ref-type="bibr" rid="B51-cells-06-00043">51</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Multiple sclerosis</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Mouse [<xref ref-type="bibr" rid="B46-cells-06-00043">46</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Pain</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Mouse, rat [<xref ref-type="bibr" rid="B52-cells-06-00043">52</xref>,<xref ref-type="bibr" rid="B53-cells-06-00043">53</xref>,<xref ref-type="bibr" rid="B54-cells-06-00043">54</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Parkinson’s disease</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Human, mouse (reviewed in [<xref ref-type="bibr" rid="B28-cells-06-00043">28</xref>])</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Schizophrenia</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Human [<xref ref-type="bibr" rid="B55-cells-06-00043">55</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">Ca<sub>v</sub>1.3</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Deafness</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Mouse [<xref ref-type="bibr" rid="B56-cells-06-00043">56</xref>,<xref ref-type="bibr" rid="B57-cells-06-00043">57</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Depression</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Human, mouse [<xref ref-type="bibr" rid="B50-cells-06-00043">50</xref>,<xref ref-type="bibr" rid="B58-cells-06-00043">58</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Pain</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Rat [<xref ref-type="bibr" rid="B52-cells-06-00043">52</xref>,<xref ref-type="bibr" rid="B53-cells-06-00043">53</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Parkinson’s disease</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Human, mouse (reviewed in [<xref ref-type="bibr" rid="B28-cells-06-00043">28</xref>])</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Ca<sub>v</sub>1.4</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">(Incomplete X-linked congenital stationary) night blindness</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Human [<xref ref-type="bibr" rid="B59-cells-06-00043">59</xref>,<xref ref-type="bibr" rid="B60-cells-06-00043">60</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Ca<sub>v</sub>2.1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Episodic ataxia type 2 and familiar hemiplegic migraine type 1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Human [<xref ref-type="bibr" rid="B61-cells-06-00043">61</xref>,<xref ref-type="bibr" rid="B62-cells-06-00043">62</xref>,<xref ref-type="bibr" rid="B63-cells-06-00043">63</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Spinocerebellar ataxia 6</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Human [<xref ref-type="bibr" rid="B64-cells-06-00043">64</xref>,<xref ref-type="bibr" rid="B65-cells-06-00043">65</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Ca<sub>v</sub>2.2</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pain</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mouse [<xref ref-type="bibr" rid="B54-cells-06-00043">54</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Ca<sub>v</sub>2.3</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Anxiety</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Mouse [<xref ref-type="bibr" rid="B66-cells-06-00043">66</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Absence epilepsy</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Mouse [<xref ref-type="bibr" rid="B66-cells-06-00043">66</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pain</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mouse [<xref ref-type="bibr" rid="B67-cells-06-00043">67</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Ca<sub>v</sub>3.1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Thalamocortical network activity/ absence epilepsy</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mouse [<xref ref-type="bibr" rid="B68-cells-06-00043">68</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Ca<sub>v</sub>3.1–3.3</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Autism/Autism spectrum disorders</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Human [<xref ref-type="bibr" rid="B69-cells-06-00043">69</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Pain</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Human, mouse, rat (reviewed in [<xref ref-type="bibr" rid="B70-cells-06-00043">70</xref>])</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Parkinson’s disease/locomotor deficits</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Rat [<xref ref-type="bibr" rid="B71-cells-06-00043">71</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Various VGCCs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Alzheimer’s disease/dementia</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mouse, rat, human (reviewed in [<xref ref-type="bibr" rid="B72-cells-06-00043">72</xref>])</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>